Vaxfab Enterprises Ltd (VEL) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Vaxfab Enterprises Ltd on NSE and BSE, with an AI summary of each filing.
Outcome of Board Meeting held on November 03, 2026 - Appointment of Forensic Auditor
Others (Uncategorized) · 03 Nov 2026, 11:21 pm
Vaxfab Enterprises Appoints ASGM & Co. for Forensic Accounting and Investigation Engagement Vaxfab Enterprises approved the appointment of ASGM & Co., Chartered Accountants, on 3rd Nov'26 to conduct an independent forensic audit and investigation covering FY23, FY24, and FY25. The audit follows management transition effective 1st Apr'25, during which historical financial, statutory, and accounting documents were incompletely handed over, alongside queries from GST authorities regarding historical transactions and input tax credit. The engagement will examine accounting integrity, reconciliations, related-party transactions, and potential statutory exposures for an approved professional fee of ₹3,00,000 plus applicable taxes.
Outcome of Board Meeting - Appointment and Resignation of Company Secretary and Compliance Officer
Others (Uncategorized) · 16 Oct 2026, 11:24 pm
Vaxfab Enterprises Appoints Dhruvi Patel as CS and Compliance Officer Vaxfab Enterprises Limited announced key management changes approved during its Board meeting on 16th Oct'26. The Board accepted the resignation of Mrs. Neha Rishabh Bardia from the position of Company Secretary and Compliance Officer due to personal reasons, relieving her effective from the close of working hours on 16th Oct'26. Concurrently, based on the Nomination and Remuneration Committee's recommendation, the Board appointed Mrs. Dhruvi Patel (ICSI Membership No. ACS-81388) as the new Company Secretary and Compliance Officer, effective 16th Oct'26.
Raising of funds through right issue
Others (Uncategorized) · 01 Oct 2026, 10:38 pm
Vaxfab Enterprises Board Approves Rights Issue Up To Rs 45 Crore Vaxfab Enterprises Limited's Board of Directors approved raising funds up to Rs 45.00 crore through a Rights Issue of equity shares with a face value of Rs 10.00 each on 1st Oct'26. The board also approved the Draft Letter of Offer to be filed with BSE Limited and constituted a Rights Issue Committee headed by Managing Director Ravindra Ashokbhai Joshi. Issue terms, entitlement ratio, pricing, and the record date will be determined subsequently by the committee, subject to requisite regulatory and statutory approvals.
Outcome of board meeting held on today October 01, 2026.
Outcome · 01 Oct 2026, 10:30 pm
Vaxfab Enterprises Approves Rights Issue of Up to Rs 45 Crore The Board of Directors of Vaxfab Enterprises Ltd approved raising funds up to Rs 45 crore via a rights issue of equity shares with a face value of Rs 10.00 each on 1st Oct'26. The board also approved the Draft Letter of Offer for filing with BSE Limited and constituted a Rights Issue Committee headed by Chairman Ravindra Ashokbhai Joshi. Issue terms, pricing, entitlement ratio, and record date will be determined subsequently, subject to statutory and regulatory approvals.
Voting result together with Scrutinizer report for the 43rd Annual general meeting of the company held on 29th September 2026.
Annual General Meeting · 01 Oct 2026, 12:12 am
outcome of 43rd annual general meeting of the company held on Tuesday 29th September 2026
Annual General Meeting · 29 Sept 2026, 11:36 pm
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/10/2026 ,inter alia, to consider and approve businesses as attached
Intimation · 25 Sept 2026, 10:08 pm
Vaxfab Enterprises Board to Consider Fund Raising on 1st Oct'26 Vaxfab Enterprises Ltd announced a Board of Directors meeting scheduled for 1st Oct'26 to consider augmenting financial resources via fund raising. The proposal includes issuing equity shares, convertible instruments, or other securities through preferential allotment, rights issue, QIP, ADR, GDR, FCCB, or alternative methods in one or more tranches. Consequently, the trading window for dealing in company securities was closed for designated persons and immediate relatives on 25th Sep'26 and will remain closed until 48 hours post the conclusion of the board meeting.
clarification that annual general meeting will be held on September 29 2026
Annual General Meeting · 08 Sept 2026, 4:19 pm
notice of the Annual general meeting to be held on September 08 2026.
Annual General Meeting · 08 Sept 2026, 4:13 pm
ANNUAL REPROT FOR FY 2025-2026
Others (Uncategorized) · 08 Sept 2026, 4:10 am
Annual Report including Notice of AGM
Annual General Meeting · 08 Sept 2026, 4:02 am
As attached
Others (Uncategorized) · 07 Sept 2026, 7:20 pm
Vaxfab Enterprises Board Approves Authorized Share Capital Hike to Rs 50 Crore Vaxfab Enterprises Limited's board approved increasing its authorized share capital from Rs 35.00 crore (comprising 3.47 crore equity shares and 3.00 lakh preference shares of Rs 10 each) to Rs 50.00 crore (comprising 4.97 crore equity shares and 3.00 lakh preference shares of Rs 10 each). The board also scheduled the 43rd Annual General Meeting for 29th Sep'26, setting the remote e-voting cut-off date as 22nd Sep'26 and the voting window from 26th Sep'26 to 28th Sep'26.
Allotment of Equity Shares
Others (Uncategorized) · 17 Aug 2026, 10:09 pm
Vaxfab Allots Equity Shares on Warrant Conversion, Expands Capital Base On 17-Aug-26, Vaxfab Enterprises allotted 8,26,761 equity shares of Rs. 10 face value at an issue price of Rs. 21.02 per share. This resulted from the conversion of warrants previously issued on a preferential basis to nine investors. Consequently, the company's paid-up equity share capital increased to Rs. 25.83 crore, comprising 2,58,26,406 equity shares. The new shares will rank pari-passu with existing equity shares. The conversion involved an exercise price payment of Rs. 15.765 per share.
Allotment of Equity shares
Others (Uncategorized) · 17 Aug 2026, 10:03 pm
Vaxfab Allots Equity Shares on Warrant Conversion Vaxfab Enterprises’ board approved the allotment of 826,761 new equity shares on 17 Aug'26. The shares, with a face value of Rs. 10 each, were issued at a price of Rs. 21.02 upon the conversion of warrants on a preferential basis. This action has increased the company's paid-up equity share capital to Rs. 25.83 crore, comprising 2,58,26,406 equity shares. The newly allotted shares will rank pari-passu with existing equity shares, resulting in an equity dilution.
As attached
Outcome · 15 Aug 2026, 3:37 am
Vaxfab Enterprises Reports Q1FY27 Loss; Auditor Issues Qualified Opinion Vaxfab Enterprises reported a consolidated net loss of ₹306.20 lacs for Q1FY27, compared to a loss of ₹323.52 lacs in Q4FY26. Revenue from operations for the quarter ended 30th Jun'26 stood at ₹40.00 lacs. Auditors issued a qualified conclusion on the results, citing inadequacies in prior-period record-keeping by previous management. They were unable to obtain sufficient audit evidence on the completeness and accuracy of sales, purchases, inventory, and trade balances, which could have a material impact on the financial position.
As attached
Financial Result · 15 Aug 2026, 3:34 am
Vaxfab Q1FY27 Results Marked by Qualified Auditor Opinion and Net Loss Vaxfab Enterprises reported a consolidated net loss of ₹306.20 lacs for Q1FY27, a significant decline from a net loss of ₹323.52 lacs QoQ. Revenue from operations was ₹40.00 lacs. The statutory auditor issued a qualified opinion on both standalone and consolidated results for the quarter ended 30th Jun'26. The qualification stems from the inability to obtain sufficient audit evidence regarding balances and transactions due to inadequate records from previous management, potentially having a material and pervasive impact on the financials.
Intimation of Incorporation of Wholly Owned Subsidiary
Others (Uncategorized) · 12 Aug 2026, 12:21 am
Vaxfab Enterprises Establishes Wholly Owned Subsidiary in UAE Vaxfab Enterprises Limited has incorporated a wholly owned subsidiary, "Al Rafa Enterprise FZ-LLC," in the United Arab Emirates on 6 Aug'26. The new entity, established with an initial cash capital and an acquisition cost of AED 1,000 per share, is yet to commence operations. The subsidiary's licensed business activities include seeds trading, packing materials, plastic raw materials trading, IT consulting, and general trading within the Ras Al Khaimah Economic Zone. This move signals an international expansion for Vaxfab.
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve as attached
Intimation · 14 Aug 2026, 5:30 am
Vaxfab Enterprises to Announce Q1 FY27 Results on 14th Aug'26 Vaxfab Enterprises (VEL) has scheduled a Board of Directors meeting on 14th Aug'26 to consider and approve its unaudited financial results for the quarter ended 30th Jun'26. In connection with this, the trading window for designated persons has been closed from 1st Jul'26 and will reopen 48 hours after the results are submitted to the stock exchanges. This meeting is pivotal for assessing the company's Q1 FY27 performance.
As attached
Others (Uncategorized) · 07 Jul 2026, 8:06 pm
Financial Results as on 31.03.2026
Financial Result · 02 Jun 2026, 1:16 am
Vaxfab Enterprises Ltd - Financial Result for the Quarter ended 31st Mar'26 (Consolidated, INR Lacs) ■ Revenue: 4,599 (+89.9% YoY | +193.6% QoQ) ■ EBITDA: -1,060 (-67.9% YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -23.1 (+303 bps YoY | Profit to Loss QoQ) ■ PAT: 214 (+169.0% YoY | Loss to Profit QoQ) ■ EPS (INR): 0.26 (+188.9% YoY | Loss to Profit QoQ)
Outcome of Board Meeting
Outcome · 31 May 2026, 4:57 am
Vaxfab Enterprises Ltd - Financial Result for the Quarter ended 31st Mar'26 (Standalone, INR Lakh) ■ Revenue: 883 (-84.9% YoY | -43.6% QoQ) ■ EBITDA: -255 (Profit to Loss YoY | Profit to Loss QoQ) ■ EBITDA Margin (%): -28.9 (Profit to Loss YoY | Profit to Loss QoQ) ■ PAT: 302 (+328.7% YoY | +1212.4% QoQ) ■ EPS (INR): 3.59 (+327.4% YoY | +1229.6% QoQ)
Vaxfab Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve as attached
Intimation · 30 May 2026, 5:30 am
Vaxfab Enterprises Sets Board Meeting for Q4 & FY26 Financial Results Vaxfab Enterprises (BSE: 542803) has scheduled a Board of Directors meeting on Sat, 30 May'26. The agenda includes the consideration and approval of the audited financial results for the quarter and full year ended Mar 31, 2026. The trading window for designated persons has been closed since Apr 01, 2026, and will reopen 48 hours after the results are submitted to the exchanges.
as attached
Others (Uncategorized) · 11 May 2026, 10:40 pm
Vaxfab Enterprises Corrects Share Allotment Figure from Warrant Conversion Vaxfab Enterprises clarified on 11 May'26 that it allotted 14,81,068 equity shares of Rs. 10 face value at a price of Rs. 21.02 per share. This allotment, resulting from the conversion of warrants, was initially reported with an incorrect share count due to a clerical error. The company's paid-up equity share capital has now increased to Rs. 24.99 crore, comprising 2,49,99,645 shares. The conversion involved six investors exercising their warrants at a price of Rs. 21.02 per share.
As attached
Others (Uncategorized) · 11 May 2026, 3:02 pm
Vaxfab Enterprises Allots 1.95M Equity Shares Post Warrant Conversion On 11 May'26, Vaxfab Enterprises' board approved the allotment of 1,950,348 new equity shares upon conversion of warrants. The shares, with a face value of Rs. 10 each, were issued at a price of Rs. 21.02 per share on a preferential basis. This action has increased the company's paid-up equity share capital to Rs. 25.47 crore, comprising 25,468,925 equity shares. The newly allotted shares will rank pari-passu with existing equity shares, resulting in a significant equity dilution for the company.
As attached
Others (Uncategorized) · 24 Apr 2026, 4:34 pm
Vaxfab Enterprises Allots Equity Shares on Warrant Conversion On 24 Apr'26, Vaxfab Enterprises' board approved the allotment of 13,18,550 equity shares (face value Rs. 10) at an issue price of Rs. 21.02 each. This action follows the conversion of outstanding warrants on a preferential basis. Consequently, the company's paid-up equity share capital has increased to Rs. 23.51 crore, comprising 2,35,18,577 equity shares. The newly allotted shares will rank pari-passu with existing equity shares, leading to an expansion of the equity base and potential earnings per share dilution.